First published 10/3/2026, 7:18:15 PM · Last updated 10/3/2026, 7:18:15 PM

Metabolic pathway of dibenzoylmethane, a β-diketone analogue of curcumin, by NADPH-dependent cytochrome P450 enzymes in mouse liver microsomes

A journal article from the Journal of Food and Drug Analysis and Taiwan's Food and Drug Administration describes a study of how dibenzoylmethane is metabolized by NADPH-dependent cytochrome P450 enzymes in mouse liver microsomes. The source is a cited journal article without additional contextual details in the provided excerpt.

Categories: science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 4/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article documents biochemical metabolism of a curcumin analogue relevant to research on drug metabolism.

Sources

Metabolic pathway of dibenzoylmethane, a β-diketone analogue of curcumin, by NADPH-dependent cytochrome P450 enzymes in mouse liver microsomesMetadata provided by Crossref. Usage terms

Report an issue